Nevro Corp. is a medical device company focused on delivering innovative solutions for the management of chronic pain. The primary function of Nevro is to provide advanced neuromodulation solutions, particularly through its flagship product, the Senza Spinal Cord Stimulation (SCS) System. This system is designed to alleviate chronic pain by using high-frequency electrical pulses to inhibit pain signals before they reach the brain. Nevro's technology is clinically proven to help patients who do not find relief through conventional pain management strategies. Operating primarily within the healthcare sector, Nevro has a significant impact on the medical device industry, continually working to improve patient outcomes and quality of life. Nevro Corp. holds an influential position in the market by pioneering research and development efforts that enhance the effectiveness and reach of neuromodulation therapies.